Treatment of Autonomic Neuropathy: Glucose Management, Blood Pressure, and Lipid Optimization
In people with diabetes, autonomic neuropathy can develop or worsen over time. An evidence-based approach addresses glucose control, weight, blood pressure, and lipid levels to prevent onset or slow progression — and treats autonomic symptoms directly to improve quality of life.
Clinical ApproachManagement targets glucose, weight, blood pressure, and lipid levels — the factors relevant to preventing or delaying neuropathy in type 1 diabetes and slowing progression in type 2 diabetes — alongside systematic assessment and treatment of autonomic symptoms; the full protocol specifies the complete clinical sequence and decision points for each domain.
Optimize glucose management to prevent or delay the development of neuropathy in people with type 1 diabetes and to slow the progression of neuropathy in people with type 2 diabetes.
Optimize weight, blood pressure, and lipid management to reduce the risk or slow the progression of diabetic neuropathy.
Assess and treat pain related to diabetic peripheral neuropathy and symptoms of autonomic neuropathy to improve quality of life.
View source ↗